Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2005
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1692122A New etonogestrel esters
11/02/2005CN1692102A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
11/02/2005CN1690073A Steroid derivatives
11/02/2005CN1225267C Medicine for treating endocrine infiltrative exophthalmos
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960599 Dopamine D2 receptor and 5-HT1A antagonists; schizophrenia; cognitive activators; Alzheimer's disease; brain disorders; strokes; antiischemic agents; anxiolytic agents; obsessive compulsive disorder; eating, sleeping and sexual disorders
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
10/2005
10/27/2005WO2005100388A1 Production of insulinotropic peptides
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005034972A3 Use of pharmaceutical compositions containing evening primrose oil for the treatment of xerostomia
10/27/2005US20050240017 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239796 tert-butyl4-{(3,4-dimethoxyphenethyl)[2-(1H-indol-3-yl)acetyl]amino}-1-piperidine carboxylate; somatostatin receptors modulator; anticarcinogenic agent; acromegalia, hypophyseal adenomas, endocrine gastroenteropancreatic tumors including carcinoid syndrome; reducing amination of N-substituted piperidone
10/27/2005US20050239711 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
10/27/2005US20050239698 placental growth factor (PLGF) capable of promoting neovascularization in the treatment of diseases and pathological alterations involving the cutaneous or subcutaneous connective tissue, scleroderma and skin ageing due to exposure to chemicals or solar radiation
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050238578 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders
10/27/2005CA2563578A1 Diagnostic and therapeutic applications of soluble lhcgr protein
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/27/2005CA2561296A1 Crystalline polymorph of bazedoxifene acetate
10/27/2005CA2561014A1 Thioamide derivatives as progesterone receptor modulators
10/27/2005CA2561010A1 Crystalline polymorph of bazedoxifene acetate
10/27/2005CA2561004A1 Bazedoxifene ascorbate as selective estrogen receptor modulator
10/26/2005EP1589115A2 Polymorphisms of the human organic anion transporting polypeptide-C (OATP-C)
10/26/2005EP1589009A1 Vitamin d3 lactone derivative
10/26/2005EP1587827A1 Obesity-related genes
10/26/2005EP1587779A1 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity
10/26/2005EP1587479A2 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
10/26/2005EP1501859B1 17a-FLUOROALKYL-11BETA-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS
10/26/2005EP1381607B1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/26/2005EP1368001B1 Pharmaceutical formulation comprising bicalutamide
10/26/2005EP1361881B1 Steroid hormone products and methods for preparing them
10/26/2005EP1246626B1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance
10/26/2005EP1140148B1 Shelf-stable solution formulation of glucagon-like peptide-1
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688583A Organic compounds as agents for the treatment of aldosterone mediated conditions
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1688299A Suppression of cytotoxic protein conformers
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958342 For use as sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent in treatment of insomnia; differential scanning calorimetry
10/25/2005CA2331009C Compositions and methods of treatment for conditions responsive to testosterone elevation
10/20/2005WO2005097151A1 Antioxidant composition and products containing the same
10/20/2005WO2003002094A8 Enhanced pharmacokinetic profile of hydrophobic substances
10/20/2005US20050234223 Drug candidate compounds such as H3 receptor inverse agonists can be screened more easily and efficiently
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234079 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy] benzyl]thiazolidine-2,4-dione potassium salt
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234051 5-Substituted 2-aryl-4 pyrimidinones
10/20/2005US20050234028 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol
10/20/2005US20050233969 Analogues of GLP-1
10/20/2005US20050233447 A cell simultaneously expressing albumin protein and a membrane-associated CD14 surface antigen; expresses a mRNA sequence typical of hepatocytes selected from the group consisting of alpha-fetoprotein, carbamyl phosphate synthetase I, coagulation factor II, and coagulation factor VII
10/20/2005CA2563541A1 D-homo-17-chloro-16(17)ene steroids
10/20/2005CA2560966A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/19/2005EP1586641A2 Compounds for the treatment of hypercalcemia and hypocalcemia
10/19/2005EP1586325A1 Drugs containing galectin 9
10/19/2005EP1586309A1 Polymeric delivery formulations of leuprolide with improved efficacy
10/19/2005EP1585727A1 Indoles useful in the treatment of androgen-receptor related diseases
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005EP1250138B1 Fulvestrant formulation
10/19/2005EP1165055B1 Pharmaceutical composition containing estradiol or ethinylestradiol and an extrusion additive
10/19/2005CN1684709A Medicine carrier for local application
10/19/2005CN1684705A Methods of use of compounds with preptin function
10/19/2005CN1684694A Inhibition of protein kinase C alpha for treatment of diabetes mellitus and cardiovascular diseases
10/19/2005CN1684690A 17beta-estradiol/levonorgestrel transderm patch for hormone replacement therapy
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1682997A Medicine for treating sub health and endocrine disorder and preparing method
10/19/2005CN1682682A Hair tension and hardness improving agent
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956051 amphiphilic drug-oligomer conjugates comprising a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety; therapeutic agents coupled to amphiphilic oligomers
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095373A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095372A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005094881A1 Antibody drug
10/13/2005WO2005094849A1 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm
10/13/2005WO2004096118A3 Composition for improving cognition and memory
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226813 Labelled somatostatin analogs backbone cyclized through metal complexation
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2561732A1 Antibody drug
10/12/2005EP1583555A1 Use of somatostatin analogs in sleep apnea
10/12/2005EP1194421B1 Selective npy (y5) antagonists
10/12/2005CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681514A A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 290